SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 113 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $18,000 | -25.0% | 32,283 | -26.8% | 0.00% | -100.0% |
| Q1 2016 | $24,000 | +118.2% | 44,101 | +271.7% | 0.00% | – |
| Q4 2015 | $11,000 | -86.6% | 11,864 | -88.3% | 0.00% | -100.0% |
| Q3 2015 | $82,000 | +156.2% | 101,660 | +675.6% | 0.00% | 0.0% |
| Q1 2015 | $32,000 | +3.2% | 13,108 | +6.8% | 0.00% | 0.0% |
| Q4 2014 | $31,000 | -63.1% | 12,277 | +3.8% | 0.00% | -50.0% |
| Q3 2014 | $84,000 | -11.6% | 11,833 | -41.1% | 0.00% | +100.0% |
| Q4 2013 | $95,000 | +86.3% | 20,082 | +95.7% | 0.00% | 0.0% |
| Q3 2013 | $51,000 | – | 10,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |